Pharmacogenetics of Psychiatric Diseases
A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Molecular Genetics and Genomics".
Deadline for manuscript submissions: 20 October 2024 | Viewed by 57
Special Issue Editor
Special Issue Information
Dear Colleagues,
Pharmacogenetics holds promise for a near Copernican revolution in psychiatry, where the current guideline-based, trial-and-error strategy has been known to lead to periods of untreated disorders, poor compliance, and various side effects. Pharmacogenetics, moreover, holds the potential to contribute to scientific development by allowing precision medicine to become the common treatment strategy in hospitals. The relevance of this field has been supported by emerging international guidelines in pharmacogenetics. However, implementable results, especially in the field of pharmacodynamics, currently lag behind expectations. There are numerous internationally coordinated initiatives underway to remove obstacles facing the application of pharmacogenetics in psychiatry. Nevertheless, the clinical diversity in therapy outcomes that has been found can only be partially explained by the validated pharmacogenomic markers that are already in place. It is necessary, therefore, to conduct additional research.
Given this knowledge, original research, reviews, and creative means of covering a variety of pharmacogenetics-related subjects in psychiatry are welcome in this Special Issue. The use of pharmacogenetics in clinical practice, the development of legislative tools and infrastructure related to pharmacogenetics, the search for novel pharmacogenetic markers specific to psychiatric treatments, the importance of epigenetics and rare genetic variants in pharmacogenetics, and innovative protocols for pharmacogenetic research are just a few of the subjects welcome.
Dr. Antonio Drago
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pharmacogenetics
- precision medicine
- psychiatry
- genetic markers
- rare variants
- PRS
- molecular pathway analysis
